Mytrex Health Technologies (ROCO:4431) Valuation Rank

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:4431 Mytrex Health Technologies Inc ROCO:4431
64 GF Score
Price NT$17.35
GF Value NT$37.17
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Mytrex Health Technologies Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Mytrex Health Technologies Valuation Rank Related Terms

ROCO:4431
64GF Score
Mytrex Health Technologies Inc ROCO:4431
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mytrex Health Technologies (ROCO:4431) Overvalued in 2026?

Based on GuruFocus' analysis, Mytrex Health Technologies stock appears to be undervalued. The current stock price of NT$17.35 is trading 53.3% below its estimated GF Value™ of NT$37.17. GuruFocus considers Mytrex Health Technologies to be Significantly Undervalued.

Key valuation signals for ROCO:4431:

  • Valuation Rank:
  • GF Value™: NT$37.17 vs. price of NT$17.35 (53.3% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the ROCO:4431 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mytrex Health Technologies Business Description

Address No. 545, Section 2, Hezhen North Road, Zhongli District, Taoyuan, TWN, 32060
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.
64GF Score

Get the complete analysis for ROCO:4431

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$17.35
Price
NT$37.17
GF Value